STACI BUTLER: Open Payments
NPI 1215545116 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,155 in 60 payments from 15 companies in 2025. Trend: 2023 $519 · 2024 $840 · 2025 $1,155
Food & beverage: $1,155
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $198 |
| Lundbeck LLC | 14 | $179 |
| Neurocrine BioSciences, Inc. | 5 | $106 |
| ABBVIE INC. | 4 | $95 |
| Vanda Pharmaceuticals Inc. | 4 | $88 |
| Teva Pharmaceuticals USA, Inc. | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $71 |
| Indivior Inc. | 3 | $60 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
Products named: ARISTADA, REXULTI, INGREZZA, ABILIFY ASIMTUFII, VRAYLAR, CAPLYTA, FANAPT, SUBLOCADE.
Industry payments across MD — which companies pay providers there.
